最新の財務情報、事業戦略、社員インタビューなど、タケダの”今“が良くわかる情報をメールでお届けします。 タケダは、常に患者さんを中心に考えるグローバルな研究開発型バイオ医薬品のリーディングカンパニーです。

Takeda operates two primary bases in Japan in Osaka and Tokyo. Its United States subsidiary is based in Cambridge, Massachusetts , and all Global Operations outside Japan and the U.S. are based in Opfikon (Zurich), Switzerland.

2024年12月13日 · Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth. Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.

Our passion and pursuit of life-transforming treatments for patients are deeply rooted in our distinguished history in Japan since 1781. Takeda's vision is to discover and deliver life-transforming treatments guided by our commitment to patients, our people, and the planet.

6 天之前 · Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company with a history of over 235 years and a presence in approximately 80 countries.

武田薬品工業株式会社 （たけだやくひんこうぎょう、 英: Takeda Pharmaceutical Company Limited）は、 大阪府 大阪市 中央区 道修町 四丁目と 東京都 中央区 日本橋本町 二丁目に本社を置く 日本 の大手 製薬会社 である。 タケダ 、 Takeda 、 武田薬品 とも略称される。 日本の メガ・ファーマ であり、積極的な M&A によって業績を拡大し続けている。 東証 プライム市 …

As a leading pharmaceutical company in Japan, we believe that we can make a difference in the healthcare industry, practice of medicine and, most importantly, in the lives of patients in Japan.

2022年3月31日 · Information on the corporate headquarters of Takeda Pharmaceutical Company Limited, Japan office locations, and key facts about the company.

2025年1月21日 · Delivering technology solutions from the Takeda Japan Innovation Centre to support various Business Units/Functions (BU/BF) in Japan, including the Japan Business Unit, R&D Japan Business Unit, Japan Corporate Functions (HR, TBS, Global Finance, GREFP, Ethics and Compliance, Legal and Corporate Affairs), and Japan GMS/GQ.

2024年12月5日 · The expected divestment of Teva-Takeda, Teva's business venture in Japan, which includes generics products and legacy products, will allow Teva to focus on bringing its innovative medicines to the Japanese market